Plexus (NASDAQ:PLXS) Lowered to Buy Rating by Wall Street Zen

Wall Street Zen lowered shares of Plexus (NASDAQ:PLXS) from a strong-buy rating to a buy rating in a research report sent to investors on Sunday.

Several other equities research analysts have also weighed in on PLXS. Benchmark raised their price objective on Plexus from $160.00 to $165.00 and gave the stock a “buy” rating in a research note on Monday, September 22nd. Stifel Nicolaus set a $140.00 price objective on Plexus in a research note on Thursday, July 24th. Sidoti raised Plexus from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $135.00 to $150.00 in a research note on Friday, July 25th. Needham & Company LLC reduced their price objective on Plexus from $162.00 to $158.00 and set a “buy” rating for the company in a research note on Thursday, July 24th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Plexus in a research note on Wednesday, October 8th. Three equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, Plexus currently has an average rating of “Moderate Buy” and a consensus target price of $155.60.

Plexus Stock Performance

PLXS opened at $148.52 on Friday. The company has a market capitalization of $4.01 billion, a price-to-earnings ratio of 25.30 and a beta of 0.80. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.58 and a quick ratio of 0.74. Plexus has a 1-year low of $103.43 and a 1-year high of $172.89. The business has a 50 day moving average price of $139.44 and a two-hundred day moving average price of $132.88.

Plexus (NASDAQ:PLXS) last announced its quarterly earnings data on Wednesday, July 23rd. The technology company reported $1.90 EPS for the quarter, beating analysts’ consensus estimates of $1.71 by $0.19. The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. Plexus had a return on equity of 12.33% and a net margin of 4.04%.The company’s quarterly revenue was up 6.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.45 EPS. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. Research analysts predict that Plexus will post 5.9 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CAO Angelo Michael Ninivaggi, Jr. sold 1,576 shares of the stock in a transaction on Monday, August 25th. The stock was sold at an average price of $137.78, for a total value of $217,141.28. Following the completion of the sale, the chief accounting officer owned 24,495 shares in the company, valued at $3,374,921.10. This represents a 6.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Patrick John Jermain sold 2,500 shares of the stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $137.71, for a total value of $344,275.00. Following the completion of the sale, the chief financial officer owned 20,959 shares of the company’s stock, valued at $2,886,263.89. The trade was a 10.66% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 15,856 shares of company stock valued at $2,142,440. 1.76% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Plexus

Hedge funds have recently modified their holdings of the stock. Huntington National Bank increased its stake in shares of Plexus by 41.5% in the second quarter. Huntington National Bank now owns 324 shares of the technology company’s stock worth $44,000 after acquiring an additional 95 shares during the last quarter. TD Private Client Wealth LLC increased its stake in shares of Plexus by 185.6% in the first quarter. TD Private Client Wealth LLC now owns 514 shares of the technology company’s stock worth $66,000 after acquiring an additional 334 shares during the last quarter. Banque Transatlantique SA acquired a new position in shares of Plexus in the first quarter worth $71,000. CWM LLC increased its stake in shares of Plexus by 65.7% in the second quarter. CWM LLC now owns 537 shares of the technology company’s stock worth $73,000 after acquiring an additional 213 shares during the last quarter. Finally, EverSource Wealth Advisors LLC increased its stake in shares of Plexus by 583.3% in the second quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company’s stock worth $78,000 after acquiring an additional 490 shares during the last quarter. 94.45% of the stock is owned by institutional investors and hedge funds.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.